Filing Details
- Accession Number:
- 0001415889-25-013817
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-20 17:00:12
- Reporting Period:
- 2025-05-16
- Filing Date:
- 2025-05-20
- Accepted Time:
- 2025-05-20 17:00:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1907108 | Lexeo Therapeutics Inc. | LXEO | Biological Products, (No Disgnostic Substances) (2836) | 854012572 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1995009 | Jenny Robertson | C/O Lexeo Therapeutics, Inc. 345 Park Avenue South, Floor 6 New York NY 10010 | Chief Legal Officer | No | No | No | No |
Transaction Summary
| Sold: | 521 shares | Avg. Price: $2.77 | Total Value: $1,445.25 |
| Number of Shares After Transactions: | 63,098 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-05-16 | 521 | $2.77 | 63,098 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs").
- Includes 52,577 restricted stock units.
Billionaire Hedge Funds
